Triplet Therapy for Relapsed or Refractory Multiple Myeloma May Improve Clinical Outcomes
Pomalidomide, cyclophosphamide, and dexamethasone triplet therapy for relapsed/refractory multiple myeloma had an overall response rate of 76%.
All articles by Megan Garlapow, PhD
Increased Risk for Mental Health Disorders Seen With Head and Neck Cancers
Mental health disorders may be an adverse effect of head and neck cancer diagnosis, treatment, or treatment morbidities.
Addressing the Need for Palliative Care Integration Into Phase 1 Clinical Trials
Researchers argue that palliative care integration into treatment regimens contribute to improving the quality of life for patients in phase 1 clinical trials.
Preparing Nurses for Possible Adverse Events with CAR-T Therapy
A multidisciplinary program developed to educate nurses on recognizing and managing the signs and symptoms of CAR-T cell therapy adverse effects.
Using Harm Reduction to Mitigate Opioid Addiction in Patients With Cancer
This approach to managing opioid misuse/diversion and addiction in oncology patients stresses use harm reduction, instead of an attempt at abstinence or addiction treatment.
Evidence-Based Approach Improves Tobacco Cessation Among Cancer Patients
Tobacco-cessation program at an ambulatory cancer center sought to reduce smoking among patients undergoing treatment for cancer.
Striving for Consistent Documentation of Pain Assessments, Patient Satisfaction
Novel innovations enhanced nurse education on pain assessment a re-assessment that enhanced patient satisfaction, although documentation still lagged at the end of the project.
Cardiovascular, Thromboembolic Mortality Risk Factors in Multiple Myeloma
An analysis of SEER data identified the risk for these cardiovascular events and the common related causes of death among patients with MM.
A Report on Longitudinal Data on Outcomes in Myeloproliferative Neoplasms Patient Registry
Researchers review the myMPN patient registry and provide an analysis of the data being collected by the registry, as well as future goals.
Baseline Pain Scores Predict PostRadiotherapy Pain in Breast Cancer
Prospective, longitudinal study sought to determine the risk factors for developing pain in women with breast cancer undergoing adjuvant radiotherapy.
Next post in Breast Cancer
